Empower your treatment planning with the MyRisk® Hereditary Cancer Test

As a surgeon, you need clear and timely information to determine the best surgical and treatment options for your patients, whether they have been diagnosed with cancer or are at high risk of developing it. With over 30 years of experience in actionable genetic insights, Myriad Genetics is your trusted partner in precision medicine. The MyRisk Hereditary Cancer Test provides fast and comprehensive results to help inform treatment decisions for patients with cancer, and accurately stratifies risk to create personalized medical management plans for those with a high risk of developing cancer. Get the answers you need for eligible, surgery-pending patients in just 5-12 days with MyRisk STAT.

MyRisk is more than a test

MyRisk goes beyond traditional testing by delivering personalized care plans and guidance through the MyRisk Management Tool. This powerful tool helps you and your patients work together to understand their personalized cancer risk, enabling you to make more informed treatment decisions. By leveraging genetic insights, you can create tailored patient management strategies that aim to detect cancer at an earlier, more treatable stage.

  • Comprehensive Insights

    MyRisk provides a complete picture of your patient’s genetic risk factors, analyzing 48 genes associated with one or more of the 11 cancer sites. Combined with RiskScore®, our comprehensive solution gives you the necessary insights to make informed decisions across your patient’s clinical journey.

  • Clinically Actionable Results

    MyRisk delivers clinically actionable data with the lowest VUS rates in the industry, including BRCA1/BRCA2.1 This empowers you to confidently determine when to test high-risk, unaffected patients and develop personalized treatment plans for those diagnosed with cancer. In fact, 53% of patients qualify for a medical management change with MyRisk, compared to only 10% with other hereditary cancer tests.2

  • Personalized Breast Cancer Risk Assessment

    The RiskScore component of MyRisk provides patients with a five-year and lifetime risk estimate of developing breast cancer, calculated using clinical risk factors, family history, and genetic markers. This personalized assessment helps you optimize care for your patients that have a high-risk of developing cancer.

  • Time-Saving Efficiency

    MyRisk streamlines your treatment planning process, giving you the information you need to make critical decisions for your breast cancer patients in a timely manner. With MyRisk STAT, you can receive rapid results for eligible, surgery-pending patients, saving you valuable time and ensuring optimal care.

  • Tailored Solutions and Expert Support

    Myriad offers tailored solutions designed to fit seamlessly into your workflow, backed by our extensive clinical expertise. Our dedicated patient education team and field clinical experts provide ongoing support and guidance, ensuring you have the resources you need to make the best decisions for your patients. With Myriad Complete, you’ll have access to first-class support from our team of board-certified genetic counselors and workflow solutions for integrating MyRisk into routine clinical care. Together, we can optimize care for your high-risk patients and those diagnosed with breast cancer.

Get started with Myriad Oncology Solutions

Request more information about how Myriad Oncology Solutions can benefit you/your patients.

Get started with Myriad Oncology

Request more information about how Myriad’s Oncology solutions can benefit you/your patients.

Don't know your NPI? Click Here

You agree to be contacted with newsletters, marketing or promotional materials and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in any email we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Policy.

Hidden Fields

Hidden test fields

“Genetic testing cannot be an afterthought. It needs to be one of the first things you discuss with the patient when you sit down to discuss how you will treat their cancer. Myriad’s MyRisk testing won my confidence very early on.”

Beth Dupree, MD, FACS, ABOIM

Who is MyRisk for?

Myriad MyRisk Hereditary Cancer Test product

MyRisk is designed for surgeons treating patients diagnosed with or at risk for:

  • Breast cancer*
  • Ovarian cancer
  • Prostate cancer
  • Pancreatic cancer*
  • Uterine cancer
  • Colorectal cancer
  • Skin cancer
  • Gastric cancer
  • Renal cancer
  • Lung cancer
  • Endocrine cancer

Whether you’re a community-based surgeon or part of an acute hospital setting, MyRisk offers the comprehensive genetic insights you need to make informed decisions that can improve patient outcomes and provide peace of mind.

*eligible for MyRisk STAT

Are you a health care provider or patient?

Learn more about MyRisk in our free guides.

Why choose MyRisk?


Our advanced testing methods and rigorous quality control ensure reliable results that you can trust.


MyRisk provides clear, meaningful results that guide your treatment and surgical decisions with confidence.


We work with insurance providers and offer financial assistance programs to make genetic testing accessible to all patients.

MyRisk STAT:

Faster Results, Better Outcomes

With MyRisk STAT, you can get expedited, comprehensive results for eligible surgery-pending patients in just 5-12 days. This rapid turnaround time enables you to provide timely, personalized care without compromising accuracy.

With MyRisk STAT, you can quickly develop personalized treatment plans that give your patients the best possible chance at a positive outcome.

Get results in 5-12 calendar days

With the Myriad MyRisk Hereditary Cancer Panel Report.

Comprehensive, affordable coverage

MyRisk STAT is now available for even more patients who meet criteria.

Increased certainty and actionability

The industry’s lowest BRCA1/2 VUS rates provide clarity that informs critical choices.

Streamlined ordering process

With Myriad Oncology Solutions, you can access a full range of genetic testing options, including MyRisk, with a single, convenient order.

Fill out form

Fill out the test request form online or on paper

Send sample

Send your patient’s blood or saliva sample to Myriad Genetics using the test kit

Receive results

Receive results via the online portal or mail

Information for patients

MyRisk is a powerful tool that can provide your healthcare team with valuable insights into your cancer risk and guide personalized treatment decisions to help you and your loved ones.

If you have been diagnosed with or are at risk for certain cancers, such as breast, ovarian, prostate, or pancreatic cancer, your surgeon may recommend genetic testing. By discussing your family history and personal risk factors with your healthcare provider, you can determine if MyRisk is right for you.

Remember, knowledge is power. Understanding your genetic risk can help you and your doctor make informed treatment decisions and create a personalized plan for medical management based on your 5-year and lifetime cancer risk. By discussing your specific risk factors with your healthcare provider, you can determine if MyRisk is right for you and how it can guide your care.

Take the first step towards more informed, personalized cancer care for you/your patients.

  1. Mundt E, et al. Driving Down the Rate of Variants of Uncertain Significance as the Myriad MyRisk® Multigene Panel Grows [White paper]. Myriad Genetics. Oct 2019.
  2. Myriad internal data based on MyRisk tests reported between 9/1/2021 and 02/01/2023 ordered for unaffected patients by OBGYN & Primary Care healthcare providers.